Faulty cat flea treatment

Dozens of pets up and down Britain have been mysteriously dying. Watchdog of BBC TV revealed the probable cause - Droplix Cat, an anti-flea treatment which contains the OP diazinon.
    Droplix is an established product prescribed by vets, placed on the back of a cat's neck to kill fleas. The Watchdog programme heard from five owners whose pets have died suddenly after administering the product. Bunny and Charlie Wheelwright from Solihull, West Midlands, lost two of their champion pedigrees after administering Droplix. They believe their cats were poisoned by the product. Charlie told Watchdog: "We feel that somebody is responsible. We're definitely responsible as far as putting it on. But it's not a cheap product, it's top-of-the range, and when you buy the best you expect the best results. You don't expect to kill your cat."
   
The makers of Droplix, Virbac Ltd, said that batches of Droplix Cat were recalled because of evidence of degradation in some pipettes. The company issued warnings through the trade press in November 1996, but did not warn the public until December when it put ads in some national papers.
   
Dr Christian Karst, Director of Research and Development at Virbac Ltd told Watchdog: "Suspicions were there since May but 99.9% of the product did not create any problem." Virbac also stressed that only some batches (Nos. 21-42) were affected.  
    An estimated 20,000 customers had bottles of Droplix thought to be faulty, and although they have been removed from the shelves of vet's dispensaries, it is not known how many are still in cat owner's homes. A survey of 100 cat owners carried out by Watchdog revealed that 97% were not aware of the warning.  
    After the programme, Liberal Democrat MP Paul Tyler, Convenor of the informal All Party OP Group, asked Angela Browning, the Agriculture Minister, for more details on the Droplix issue. She refused to give further information and said that: "details of data submitted in support of particular products are subject to the confidentiality requirements of section 118 of the Medicines Act 1968." She also rejected the MP's request for a suspension of Droplix's marketing licence. However on 21 February Virbac temporarily suspended the sale of Droplix anyway "to avoid further confusion and dispel and remaining fear among pet owners," the company said.

BBC News release, 23/1/97 and Paul Tyler MP, press release 12/2/97.

[This article first appeared in Pesticides News No. 35, March 1997, page 6]